Enhancing Immune Response to Cutaneous Malignancies with Imiquimod

Imiquimod is a synthetic imidazoquinolone amine, which has potent immune response modifier activity when used topically. This characteristic property of imiquimod has led to its use in a number of applications in dermatology, particularly in cutaneous malignancies, where it has been found to be effective and safe. Currently it is used to treat actinic keratosis (AK), basal cell carcinoma (BCC) and external genital warts.

Modern Medicine – Issue 5 2021